Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.0194 | 0.0194 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.1086 | 0.4417 | 0.4307 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2306 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2306 | 1 | 1 |
Plasmodium falciparum | casein kinase 2, alpha subunit | 0.2306 | 1 | 1 |
Brugia malayi | kinase, mitochondrial precursor | 0.1086 | 0.4417 | 0.4417 |
Echinococcus multilocularis | casein kinase ii subunit beta | 0.0416 | 0.1347 | 0.1176 |
Echinococcus granulosus | casein kinase ii subunit beta | 0.0416 | 0.1347 | 0.1176 |
Leishmania major | casein kinase II, putative | 0.2306 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2306 | 1 | 1 |
Trypanosoma cruzi | casein kinase II, putative | 0.2306 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.044 | 0.1459 | 0.0314 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Brugia malayi | Carboxylesterase family protein | 0.0164 | 0.0194 | 0.0194 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Brugia malayi | Csnk2b protein | 0.0416 | 0.1347 | 0.1347 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.0194 | 0.0194 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.1026 | 0.414 | 0.4025 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Onchocerca volvulus | Casein kinase II subunit beta homolog | 0.0416 | 0.1347 | 0.5 |
Trypanosoma cruzi | Casein kinase II subunit beta, putative | 0.0416 | 0.1347 | 0.0186 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.1026 | 0.414 | 0.4025 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Loa Loa (eye worm) | carboxylesterase | 0.0164 | 0.0194 | 0.0194 |
Onchocerca volvulus | Casein kinase II subunit beta homolog | 0.0416 | 0.1347 | 0.5 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2306 | 1 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.1086 | 0.4417 | 0.4307 |
Trypanosoma brucei | Casein kinase II subunit beta, putative | 0.0416 | 0.1347 | 0.0186 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.0416 | 0.1347 | 0.1347 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Entamoeba histolytica | protein kinase domain containing protein | 0.2306 | 1 | 1 |
Toxoplasma gondii | casein kinase ii regulatory subunit protein | 0.0416 | 0.1347 | 0.0186 |
Toxoplasma gondii | CMGC kinase, CK2 family | 0.2306 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.1086 | 0.4417 | 0.3668 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Trypanosoma cruzi | Casein kinase II subunit beta, putative | 0.0416 | 0.1347 | 0.0186 |
Giardia lamblia | Casein kinase II beta chain | 0.0416 | 0.1347 | 0.1347 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2306 | 1 | 1 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.1086 | 0.4417 | 0.3668 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Trypanosoma brucei | Casein kinase II | 0.2306 | 1 | 1 |
Schistosoma mansoni | protein kinase | 0.2306 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2306 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2306 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.1086 | 0.4417 | 0.4307 |
Echinococcus multilocularis | casein kinase ii subunit alpha | 0.2306 | 1 | 1 |
Giardia lamblia | Kinase, CMGC CK2 | 0.2306 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0416 | 0.1347 | 0.1347 |
Loa Loa (eye worm) | hypothetical protein | 0.1086 | 0.4417 | 0.4417 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.1086 | 0.4417 | 0.4307 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0164 | 0.0194 | 0.0194 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.0416 | 0.1347 | 0.1347 |
Toxoplasma gondii | ck2 beta subunit | 0.0416 | 0.1347 | 0.0186 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.1086 | 0.4417 | 0.3668 |
Loa Loa (eye worm) | Csnk2b protein | 0.0416 | 0.1347 | 0.1347 |
Entamoeba histolytica | casein kinase, putative | 0.2306 | 1 | 1 |
Plasmodium vivax | unspecified product | 0.2306 | 1 | 1 |
Echinococcus granulosus | casein kinase ii subunit alpha | 0.2306 | 1 | 1 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.0416 | 0.1347 | 0.1347 |
Plasmodium vivax | casein kinase 2, alpha subunit, putative | 0.2306 | 1 | 1 |
Loa Loa (eye worm) | CMGC/CK2 protein kinase | 0.2306 | 1 | 1 |
Schistosoma mansoni | casein kinase II beta subunit | 0.0416 | 0.1347 | 0.1176 |
Leishmania major | protein kinase ck2 regulatory subunit, putative | 0.0416 | 0.1347 | 0.0186 |
Brugia malayi | Carboxylesterase family protein | 0.0164 | 0.0194 | 0.0194 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.